These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 31147404)

  • 21. Comparison of 3 Different Therapeutic Particles in Radioembolization of Locally Advanced Intrahepatic Cholangiocarcinoma.
    Wagemans MEHM; Kunnen B; Stella M; van Rooij R; Smits M; Bruijnen R; Lam MGEH; de Jong HWAM; Braat AJAT
    J Nucl Med; 2024 Feb; 65(2):272-278. PubMed ID: 38176716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
    Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A
    Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
    Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
    J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    Garin E; Rolland Y; Edeline J; Icard N; Lenoir L; Laffont S; Mesbah H; Breton M; Sulpice L; Boudjema K; Rohou T; Raoul JL; Clement B; Boucher E
    J Nucl Med; 2015 Mar; 56(3):339-46. PubMed ID: 25678490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of Early Posttreatment PET/CT Evaluation Using FDG or
    Reizine E; Chalaye J; Mule S; Regnault H; Perrin C; Calderaro J; Laurent A; Amaddeo G; Kobeiter H; Tacher V; Itti E; Luciani A
    AJR Am J Roentgenol; 2022 Feb; 218(2):359-369. PubMed ID: 34494448
    [No Abstract]   [Full Text] [Related]  

  • 26. A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.
    Chiesa C; Mira M; Maccauro M; Romito R; Spreafico C; Sposito C; Bhoori S; Morosi C; Pellizzari S; Negri A; Civelli E; Lanocita R; Camerini T; Bampo C; Carrara M; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):503-8. PubMed ID: 23358402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
    J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Planning dosimetry for
    Thomas MA; Mahvash A; Abdelsalam M; Kaseb AO; Kappadath SC
    Med Phys; 2020 Oct; 47(10):5333-5342. PubMed ID: 32790882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
    Garin E; Rolland Y; Laffont S; Edeline J
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):559-75. PubMed ID: 26338177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging.
    Walrand S; Hesse M; Chiesa C; Lhommel R; Jamar F
    J Nucl Med; 2014 Jan; 55(1):135-40. PubMed ID: 24296766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry.
    D'Arienzo M; Filippi L; Chiaramida P; Chiacchiararelli L; Cianni R; Salvatori R; Scopinaro F; Bagni O
    Ann Nucl Med; 2013 Aug; 27(7):676-80. PubMed ID: 23605058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioembolization of hepatocarcinoma with
    Chiesa C; Mira M; Bhoori S; Bormolini G; Maccauro M; Spreafico C; Cascella T; Cavallo A; De Nile MC; Mazzaglia S; Capozza A; Tagliabue G; Brusa A; Marchianò A; Seregni E; Mazzaferro V
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3018-3032. PubMed ID: 32451604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Evaluation of a Three-Dimensional Internal Dosimetry Technique for Liver Radioembolization with
    Plachouris D; Mountris KA; Papadimitroulas P; Spyridonidis T; Katsanos K; Apostolopoulos D; Papathanasiou N; Hazle JD; Visvikis D; Kagadis GC
    Cancer Biother Radiopharm; 2021 Dec; 36(10):809-819. PubMed ID: 33656372
    [No Abstract]   [Full Text] [Related]  

  • 34. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.
    van den Hoven AF; Rosenbaum CE; Elias SG; de Jong HW; Koopman M; Verkooijen HM; Alavi A; van den Bosch MA; Lam MG
    J Nucl Med; 2016 Jul; 57(7):1014-9. PubMed ID: 26912436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
    Shady W; Kishore S; Gavane S; Do RK; Osborne JR; Ulaner GA; Gonen M; Ziv E; Boas FE; Sofocleous CT
    Eur J Radiol; 2016 Jun; 85(6):1224-31. PubMed ID: 27161074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors.
    Obrzut S; McCammack K; Badran KW; Balistreri A; Ou E; Nguyen BJ; Hoh CK; Rose SC
    Clin Imaging; 2017; 42():43-49. PubMed ID: 27875761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of Yttrium-90 Radioembolization Dose Calculation Utilizing Intra-procedural Open Trajectory Cone Beam CT.
    O'Connor PJ; Pasik SD; van der Bom IM; Bishay V; Radaelli A; Kim E
    Cardiovasc Intervent Radiol; 2020 Feb; 43(2):295-301. PubMed ID: 31578635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
    Allimant C; Kafrouni M; Delicque J; Ilonca D; Cassinotto C; Assenat E; Ursic-Bedoya J; Pageaux GP; Mariano-Goulart D; Aho S; Guiu B
    J Vasc Interv Radiol; 2018 Dec; 29(12):1662-1670.e4. PubMed ID: 30217745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
    Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.